Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 187

1.

Wnt/beta-Catenin pathway in human glioma: expression pattern and clinical/prognostic correlations.

Liu C, Tu Y, Sun X, Jiang J, Jin X, Bo X, Li Z, Bian A, Wang X, Liu D, Wang Z, Ding L.

Clin Exp Med. 2011 Jun;11(2):105-12. doi: 10.1007/s10238-010-0110-9. Epub 2010 Aug 31.

PMID:
20809334
2.

Immunohistochemical analyses of beta-catenin and cyclin D1 expression in giant cell tumor of bone (GCTB): a possible role of Wnt pathway in GCTB tumorigenesis.

Matsubayashi S, Nakashima M, Kumagai K, Egashira M, Naruke Y, Kondo H, Hayashi T, Shindo H.

Pathol Res Pract. 2009;205(9):626-33. doi: 10.1016/j.prp.2009.02.011. Epub 2009 Mar 25.

PMID:
19324500
3.

Alterations and correlations of the components in the Wnt signaling pathway and its target genes in breast cancer.

Ozaki S, Ikeda S, Ishizaki Y, Kurihara T, Tokumoto N, Iseki M, Arihiro K, Kataoka T, Okajima M, Asahara T.

Oncol Rep. 2005 Dec;14(6):1437-43.

PMID:
16273236
4.

Activation of Wnt/beta-catenin/Tcf signaling pathway in human astrocytomas.

Sareddy GR, Panigrahi M, Challa S, Mahadevan A, Babu PP.

Neurochem Int. 2009 Sep;55(5):307-17. doi: 10.1016/j.neuint.2009.03.016. Epub 2009 Apr 5.

PMID:
19576519
5.

beta-Catenin nuclear accumulation in head and neck mucoepidermoid carcinoma: its role in cyclin D1 overexpression and tumor progression.

Shiratsuchi H, Nakashima T, Hirakawa N, Toh S, Nakagawa T, Saito T, Tsuneyoshi M, Komune S.

Head Neck. 2007 Jun;29(6):577-84.

PMID:
17315172
6.

[Significance of beta-catenin and Cyclin D1 express in glioma].

Zhang ZQ, Chen HQ, Chen YH, Cheng XF.

Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2009 Nov;25(11):1010-2. Chinese.

PMID:
19900369
7.

Coincident expression of beta-catenin and cyclin D1 in endometrial stromal tumors and related high-grade sarcomas.

Kurihara S, Oda Y, Ohishi Y, Kaneki E, Kobayashi H, Wake N, Tsuneyoshi M.

Mod Pathol. 2010 Feb;23(2):225-34. doi: 10.1038/modpathol.2009.162. Epub 2009 Nov 6.

8.

Abnormal beta-catenin expression in oral cancer with no gene mutation: correlation with expression of cyclin D1 and epidermal growth factor receptor, Ki-67 labeling index, and clinicopathological features.

Odajima T, Sasaki Y, Tanaka N, Kato-Mori Y, Asanuma H, Ikeda T, Satoh M, Hiratsuka H, Tokino T, Sawada N.

Hum Pathol. 2005 Mar;36(3):234-41.

PMID:
15791567
9.

Aberrant nuclear localization of beta-catenin without genetic alterations in beta-catenin or Axin genes in esophageal cancer.

Kudo J, Nishiwaki T, Haruki N, Ishiguro H, Shibata Y, Terashita Y, Sugiura H, Shinoda N, Kimura M, Kuwabara Y, Fujii Y.

World J Surg Oncol. 2007 Feb 19;5:21.

10.

Wnt/beta-catenin/Tcf signaling pathway activation in malignant progression of rat gliomas induced by transplacental N-ethyl-N-nitrosourea exposure.

Sareddy GR, Challa S, Panigrahi M, Babu PP.

Neurochem Res. 2009 Jul;34(7):1278-88. doi: 10.1007/s11064-008-9906-3. Epub 2009 Jan 16.

PMID:
19148749
11.

Differential expression of galectin-3, beta-catenin, and cyclin D1 in adenoid cystic carcinoma and polymorphous low-grade adenocarcinoma of salivary glands.

Ferrazzo KL, Neto MM, dos Santos E, dos Santos Pinto D, de Sousa SO.

J Oral Pathol Med. 2009 Oct;38(9):701-7. doi: 10.1111/j.1600-0714.2009.00776.x. Epub 2009 Jul 31.

PMID:
19659475
12.

Wnt1 overexpression promotes tumour progression in non-small cell lung cancer.

Huang CL, Liu D, Ishikawa S, Nakashima T, Nakashima N, Yokomise H, Kadota K, Ueno M.

Eur J Cancer. 2008 Nov;44(17):2680-8. doi: 10.1016/j.ejca.2008.08.004. Epub 2008 Sep 13.

PMID:
18790633
13.

Nuclear beta-catenin correlates with cyclin D1 expression in spindle and pleomorphic sarcomas but not in synovial sarcoma.

Saito T, Oda Y, Yamamoto H, Kawaguchi K, Tanaka K, Matsuda S, Iwamoto Y, Tsuneyoshi M.

Hum Pathol. 2006 Jun;37(6):689-97.

PMID:
16733209
14.

PPARgamma and Wnt/beta-Catenin pathway in human breast cancer: expression pattern, molecular interaction and clinical/prognostic correlations.

Jiang Y, Zou L, Zhang C, He S, Cheng C, Xu J, Lu W, Zhang Y, Zhang H, Wang D, Shen A.

J Cancer Res Clin Oncol. 2009 Nov;135(11):1551-9. doi: 10.1007/s00432-009-0602-8. Epub 2009 Jun 3.

PMID:
19495794
15.

[Correlation among expression of E-cadherin, beta-catenin, and cyclin D1 in breast cancers].

Yang JF, Chen SL, Liu ZH, Zhang Y.

Ai Zheng. 2004 Jul;23(7):799-802. Chinese.

PMID:
15248915
16.

High Pin1 expression is associated with tumor progression in colorectal cancer.

Kuramochi J, Arai T, Ikeda S, Kumagai J, Uetake H, Sugihara K.

J Surg Oncol. 2006 Aug 1;94(2):155-60.

PMID:
16847925
17.

Significance of E-cadherin/beta-catenin complex and cyclin D1 in breast cancer.

Lim SC, Lee MS.

Oncol Rep. 2002 Sep-Oct;9(5):915-28.

PMID:
12168049
18.
19.

Expression and prognostic roles of beta-catenin in hepatocellular carcinoma: correlation with tumor progression and postoperative survival.

Inagawa S, Itabashi M, Adachi S, Kawamoto T, Hori M, Shimazaki J, Yoshimi F, Fukao K.

Clin Cancer Res. 2002 Feb;8(2):450-6.

20.

Correlation of gamma-catenin expression with good prognosis in medulloblastomas.

Misaki K, Marukawa K, Hayashi Y, Fukusato T, Minamoto T, Hasegawa M, Yamashita J, Fujisawa H.

J Neurosurg. 2005 Mar;102(2 Suppl):197-206.

PMID:
16156230

Supplemental Content

Support Center